ACM
AGIO icon

ADAR1 Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

ADAR1 Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8M Buy
1,288,053
+1,147,381
+816% +$34.8M 2.19% 7
2026
Q1 		$4.76M Sell
140,672
-47,328
-25% -$1.34M 0.28% 80
2025
Q4 		$5.12M Buy
188,000
+151,000
+408% +$5.3M 0.38% 58
2025
Q3 		$1.49M Buy
37,000
+1,100
+3% +$41.4K 0.14% 92
2025
Q2 		$1.19M Buy
35,900
+8,000
+29% +$242K 0.18% 74
2025
Q1 		$817K Buy
+27,900
New +$926K 0.15% 87
2024
Q4 		– Sell
-21,300
Closed -$946K – 219
2024
Q3 		$946K Buy
+21,300
New +$967K 0.15% 80

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

ADAR1 Capital Management's AGIO Position: Q2 2026 in Review

ADAR1 Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 816% in Q2 2026, buying an estimated $34.8M and bringing the position to 1,288,053 shares worth $47.8M. The position accounts for 2.19% of the portfolio, ranked #7.

ADAR1 Capital Management first reported a position in AGIO in Q3 2024 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • ADAR1 Capital Management held 1,288,053 shares of Agios Pharmaceuticals worth $47.8M as of Q2 2026.
  • ADAR1 Capital Management bought 1,147,381 Agios Pharmaceuticals shares in Q2 2026, an estimated $34.8M.
  • Agios Pharmaceuticals made up 2.19% of ADAR1 Capital Management's portfolio in Q2 2026, its #7 holding.
  • ADAR1 Capital Management first reported a position in Agios Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.